CIN Agar: Principle, Composition, Preparation, Uses

Cefsulodin-Irgasan-Novobiocin Agar (CIN Agar), also known asYersinia Selective Agar, is a selective and differential culture medium used to selectively isolate and identifyYersinia spp., specifically strains ofYersinia enterocolitica.

This medium was first formulated and described by Schiemann D.A. in 1979. The Schiemann’s CIN medium contained cefsulodin, irgasan, novobiocin, crystal violet, and bile salts as the major selective components besides other nutrient sources. Later, a few components are modified and amounts are adjusted to increase the efficiency of the medium. (The original composition of the CIN medium is described later below.)

Objective of CIN Agar

To selectively isolate and identifyYersinia enterocoliticastrains from fecal samples (clinical samples) and food samples.

Principle of CIN Agar

CIN中包含不同的抑制混合涂料nents and antibiotics that suppress the growth of Gram-positive and many Gram-negative bacteria; additionally, the presence of an indicator allows for the presumptive identification ofYersinia enterocoliticacolonies.

Crystal violetandsodium deoxycholate(bile salt) present in the medium suppress the growth of Gram-positive bacteria.Irgasanfurther enhances the suppression of Gram-positive bacterial and fungal growth. The combination of antibiotics likecefsulodin,irgasan, andnovobiocinsuppresses the growth of many Gram-negative and Gram-positive bacterial growths exceptYersinia enterocoliticaand few other bacteria, selectively allowingYersinia enterocoliticato overgrow other competitors.

The lactose present in the medium is readily fermentable byYersinia spp. producing organic acids as a byproduct. These produced acids will reduce the pH of the medium which is detected by the neutral red incorporated in the medium as a pH indicator.Yersiniaenterocoliticastrains are capable of fermenting lactose and producing acids; hence, they produce characteristic ‘bull’s-eye’colonies: colonies containing a central dark red/pink zone surrounded by an outer translucent zone.

Composition of CIN Agar

Original Composition Described by Schiemann D.A

The composition of Schiemann’s CIN agar as described by Schiemann D.A in “SCHIEMANN. D. A. 1979. Synthesis of a selective agar medium forYersinia enterocolitica. Can. J. Microbiol. 25: 1298- 1304” is tabulated below:

Components andQuantity

Special Peptone (Oxoid) – 20 grams

Yeast Extract (Difco) – 2 grams

Mannitol – 20 grams

Pyruvic Acid (Sodium salt) – 2 grams

钠的背影oride – 1 gram

Magnesium sulfate.7H2O – 10 milligram

(10 mL of 0.1% stock solution)

Agar (Oxoid No. 4) – 12 grams

Irgasan DP300 – 10 mL of 0.04% in 95% ethanol

Bile salts (Difco) – 2 grams in 200 mL distilled water

NaOH – 1 mL of 5N NaOH solution

Neutral Red – 10 mL of 3 mg/mL solution

Crystal Violet – 10 mL of 0.1 mg/mL solution

Cefsulodin – 10 mL of 1.5 mg/mL solution

Novobiocin – 10 mL of 1.5 mg/mL solution

Final pH (Adjusted by 5N NaOH) – 7.4

(Reference: Schiemann D. A., 1979, Synthesis of a selective agar medium for Yersinia enterocolitica. Can. J. Microbiol., 25: 1298.doi: 10.1139/m79-205. PMID: 540256.)

Modern Composition in use as per HiMedia

Most of the company supply CIN Agar Medium as CIN Agar base and supplement material. The agar base contains all the components except antimicrobial components viz. cefsulodin, irgasan, and novobiocin, which are supplied separately as selective supplements as they can’t be autoclaved like other components. HiMedia laboratories also supply in this way. They provide a CIN Agar base called Yersinia Agar Base and CTN Selective Supplement. Mixing these two products in the correct proportion will form CIN Agar for selective isolation ofY. enterocolitica.

    Components of CIN Agar per 1000 mL

    Peptone – 20.00 grams

    Yeast extract – 2.000 grams

    甘露醇- 20.00克

    Sodium pyruvate – 2.000 grams

    Sodium chloride (NaCl) – 1.000 grams

    Magnesium sulfate – 0.010 grams

    Sodium deoxycholate – 0.500 grams

    Neutral Red – 0.030 grams

    Crystal Violet – 0.001 grams

    CTN selective supplement (FD034) – 2 Vials

    Agar – 12.50 grams

    Final pH 7.4 ±0.2 at 25°C

    (Reference:https://www.himedialabs.com/media/TD/M843.pdf)

    Components per 1 Vial of CTN Selective Supplement (FD034)

    Cefsulodin – 7.500 mg

    Irgasan (Triclosan) – 2.000 mg

    Novobiocin – 1.250 mg

    (Reference:https://www.himedialabs.com/media/TD/FD034.pdf)

    Preparation of CIN Agar Medium (HiMedia)

    1. Suspend 58.04 grams of the Yersinia Agar Base medium (or the required amount of each component listed above) in 1000 mL of distilled water in a suitable conical flask or glass bottle.
    2. Dissolve well using a magnetic stirrer or shaking manually.
    3. Heat to boiling so that every component including agar dissolves completely in the water.
    4. Autoclave for 15 minutes at 121°C and 15 lbs pressure to sterilize the medium.
    5. Let the medium cool for about 45°C.
    6. Add 2 mL of sterile distilled water and 1 mL of ethanol in each vial of CTN Selective Supplement (FD034) and mix the components by gently shaking the vial. Prepare such 2 vials.
    7. When the basal medium is cooled to around 45°C, mix the 2 prepared vials of CTN Selective Supplement in the basal medium.
    8. Mix well with gentle shaking. This will form the workable CIN Agar medium.
    9. Dispense the required volume of the CIN agar medium in a petri plate or test tube and let it solidify completely before using.

    Self-life/Storage Condition

    • At 2 to 8°C and in sealed condition, the prepared medium can be stored for about 3 to 8 weeks. The unprepared media components can be stored at 10 to 30°C in a sealed container till the labeled expiration date.

    Quality Control and Colony Characters on CIN Agar

    • Unprepared medium powder with neural red indicator will appear yellow to pink colored powder; whereas, prepared and solidified medium in petri plate appears orange-red/pink colored.
    • The pH of the medium must be 7.4 ±0.2 at 25°C.
    • Cultural characters of some bacteria after 24 to 48 hours of incubation at 22 to 32°C:
    Organism Appearance
    Escherichia coliATCC 25922 No Growth/Partial Inhibition
    Pseudomonas aeruginosaATCC 27853 No Growth/Partial Inhibition
    Proteus mirabilisATCC 25933 No Growth/Partial Inhibition
    Salmonella typhimuriumATCC 14028 No Growth/Partial Inhibition
    Enterococcus faecalisATCC 29212 No Growth
    Staphylococcus aureusATCC 25923 No Growth
    Yersinia enterocoliticaATCC 27729 正增长,
    Bull’s-eye colonies- dark red/pink center with a translucent border
    CIN Agar
    Figure: Yersinia on CIN Agar. Image Source:bioMérieuxandThermo Fisher Scientific Inc.

    Precautions

    • Do not add CTN Selective Supplement before autoclaving or when the medium is above 50°C or below 40°C.
    • Use sterile distilled water to hydrate the CTN selective supplement vial.
    • Use the appropriate amount of CTN Selective Supplement otherwise other bacteria can grow.

    Limitations ofCIN Agar

    • Other Yersinia species likeY. pseudotuberculosis, Yersinia frederiksenii, Y. kristensenii, Y. intermedia等,也可以种植和生产类似的殖民地。
    • Aeromonas, Serratia liquefaciens, Citrobacter freundi,andEnterobacter agglomeransgrow and shows similar colonial characteristics.
    • The medium only provides presumptive identification.Y. enterocoliticamust be confirmed using biochemical or genetic analysis.

    Applications

    • Isolation and identification ofYersinia enterocoliticastrains from clinical (fecal) samples and food samples.

    Safety and Disposal

    • Dispose of the used medium after autoclaving or incineration.

    References

    1. Schiemann DA. Synthesis of a selective agar medium for Yersinia enterocolitica. Can J Microbiol. 1979 Nov;25(11):1298-1304. doi: 10.1139/m79-205. PMID: 540256.
    2. Sarovich DS, Colman RE, Price EP, Chung WK, Lee J, Schupp JM, Cobble KR, Busch JD, Alexander J, Keim P, Wagner DM. Selective isolation of Yersinia pestis from plague-infected fleas. J Microbiol Methods. 2010 Jul;82(1):95-7. doi: 10.1016/j.mimet.2010.03.019. Epub 2010 Apr 10. PMID: 20385178; PMCID: PMC2903439.
    3. Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1
    4. (1995). Cefsulodin Irgasan Novobiocin (CIN) agar. Progress in Industrial Microbiology, 34, 275-277. https://doi.org/10.1016/S0079-6352(05)80027-X
    5. https://www.himedialabs.com/media/TD/M843.pdf
    6. https://www.himedialabs.com/media/TD/FD034.pdf
    7. https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/122/409/95760dat.pdf
    8. https://www.dalynn.com/dyn/ck_assets/files/tech/PY47.pdf
    9. https://assets.fishersci.com/TFS-Assets/LSG/manuals/IFU1998.pdf
    10. https://www.bioz.com/result/cin%20agar/product/HiMedia%20Laboratories
    11. https://www.neogen.com/globalassets/pim/assets/original/10033/official_ncm0182_yersinia-selective-agar-schiemanns-cin-agar_technical-specifications_en-us.pdf
    12. http://emp.com.ge/culture-media/cin-agar/

    About Author

    Photo of author

    Prashant Dahal

    Prashant Dahal completed his bachelor’s degree (B.Sc.) Microbiology from Sunsari Technical College, affiliated with Tribhuvan University. He is interested in topics related to Antimicrobial resistance, the mechanism of resistance development, Infectious diseases (Pneumonia, tuberculosis, HIV, malaria, dengue), Host-pathogen interaction, Actinomycetes, fungal metabolites, and phytochemicals as novel sources of antimicrobials and Vaccines.

    Leave a Comment

    This site uses Akismet to reduce spam.Learn how your comment data is processed.